Skip to content
healthcare.dev
Get a free key

Bortezomib

NDC 67184-0530, Bortezomib, injection, powder, lyophilized, for solution, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0530
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210824
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0530 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BORTEZOMIB3.5 mg/1

Pharmacologic classes

Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/aef02171-bf8a-43ad-b40c-7642623f9802

Use it

Look up 67184-0530 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0530 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0530. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.